Frontier sites in clinical trials: Opportunities, challenges, and models
Frontier sites offer significant promise for increasing research capacity and diversity, but require substantial operational, educational, and community engagement support. These survey findings provide a foundation for shared understanding across the industry. From that foundation the industry can work to develop a playbook to guide the successful integration of frontier sites into clinical trial operations.
Institutions
- Northwest Kidney Centers (US)
- Banner Health (US)
- Moffitt Cancer Center (US)
- Clinvest (United States) (US)
- Banner Life Sciences (United States) (US)
- Primary HealthCare (MT)
- Thermo Fisher Scientific (United Kingdom) (GB)
- Národní Ústav pro Vzdělávání (CZ)
- Drexel University (US)
Publication Details
- Journal
- Contemporary Clinical Trials Communications
- Published
- 2025-11-25
- DOI
- https://doi.org/10.1016/j.conctc.2025.101581
- Primary Topic
- Ethics in Clinical Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00